HIV vaccine might offer survival advantage

June 12, 2006

U.S. researchers say even if an HIV vaccine doesn't offer perfect protection against the virus, it might provide a survival advantage after infection.

Such a survival advantage was observed in two monkey studies sponsored by the National Institute of Allergy and Infectious Diseases.

One team of researchers was led by Dr. Norman Letvin of Beth Israel Deaconess Medical Center, Harvard Medical School and the NIAID Vaccine Research Center, while the other team was led by Mario Roederer of the VRC.

Both teams found monkeys vaccinated against simian immunodeficiency virus -- a close relative of HIV that causes an AIDS-like disease in monkeys -- and then exposed to the virus survived significantly longer than unvaccinated animals exposed to SIV.

The studies also identified a measurable marker of SIV vaccine effectiveness in monkeys -- something known as an immune correlate of vaccine efficacy. But the researchers say further study is needed to determine if the immune correlate could predict the effectiveness of a vaccine against HIV in humans.

The research appears in this week's issue of Science and this month's issue of the Journal of Experimental Medicine.

Copyright 2006 by United Press International

Explore further: Monkeys able to fend off AIDS-like symptoms with enhanced HIV vaccine

Related Stories

Novel vaccine approach offers hope in fight against HIV

May 17, 2009

A research team may have broken the stubborn impasse that has frustrated the invention of an effective HIV vaccine, by using an approach that bypasses the usual path followed by vaccine developers. By using gene transfer ...

HIV vaccine strategy expands immune responses

March 3, 2010

Two teams of researchers -- including Los Alamos National Laboratory theoretical biologists Bette Korber, Will Fischer, Sydeaka Watson, and James Szinger -- have announced an HIV vaccination strategy that has been shown to ...

Some monkeys born with gene that protects against AIDS

May 4, 2011

A certain gene in some monkeys can help boost vaccine protection against simian immunodeficiency virus (SIV), a trait that could help researchers develop better AIDS vaccines for humans, suggested a study out Wednesday.

Vaccines from a reactor

March 2, 2015

In the event of an impending global flu pandemic, vaccine production could quickly reach its limits, as flu vaccines are still largely produced in embryonated chicken eggs. Udo Reichl, Director at the Max Planck Institute ...

Recommended for you

NASA's space-station resupply missions to relaunch

November 29, 2015

NASA's commercial space program returns to flight this week as one of its private cargo haulers, Orbital ATK, is to launch its first supply shipment to the International Space Station in more than 13 months.

CERN collides heavy nuclei at new record high energy

November 25, 2015

The world's most powerful accelerator, the 27 km long Large Hadron Collider (LHC) operating at CERN in Geneva established collisions between lead nuclei, this morning, at the highest energies ever. The LHC has been colliding ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.